Clinical Cancer Research

Oncology & Cancer

Genes reveal kidney cancer's risk of recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

Medications

Drug combination shows potential in aggressive leukemia

Acute myeloid leukemia (AML) is an aggressive form of cancer that originates in the bone marrow, rapidly spreads to the blood, and can quickly cause death if not treated promptly. Despite recent therapeutic advances, it continues ...

page 4 from 40